These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19278402)

  • 1. An unusual case of nightmares with galantamine.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
    [No Abstract]   [Full Text] [Related]  

  • 2. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
    Wong VS
    Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718
    [No Abstract]   [Full Text] [Related]  

  • 7. The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.
    Farlow MR
    Lancet Neurol; 2009 Jan; 8(1):22-3. PubMed ID: 19042160
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 9. Respiratory myoclonus, a side effect of galantamine.
    Hernández-Fernández F; Pardal-Fernández JM; García-Martínez E; Segura T
    Farm Hosp; 2011; 35(2):97-9. PubMed ID: 21106426
    [No Abstract]   [Full Text] [Related]  

  • 10. Galantamine-associated nightmares and anxiety.
    Corbo JM; Brown JN; Moss JM
    Consult Pharm; 2013 Apr; 28(4):243-6. PubMed ID: 23552705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.
    Stahl SM; Markowitz JS; Papadopoulos G; Sadik K
    Curr Med Res Opin; 2004 Apr; 20(4):517-24. PubMed ID: 15119989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galantamine introduced in Europe.
    Am J Alzheimers Dis Other Demen; 2001; 16(1):8. PubMed ID: 11416951
    [No Abstract]   [Full Text] [Related]  

  • 14. [Galantamine].
    Taéron C
    Rev Infirm; 2008 Sep; (143):44-6. PubMed ID: 18788671
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia.
    Warner J; Butler R
    Clin Evid; 2002 Jun; (7):846-66. PubMed ID: 12230710
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine: a new alzheimer drug with a past life.
    Pearson VE
    Ann Pharmacother; 2001 Nov; 35(11):1406-13. PubMed ID: 11724094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia.
    Warner J; Butler R; Jackson E
    Clin Evid; 2002 Dec; (8):927-50. PubMed ID: 12603921
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous pemphigoid precipitated by galantamine hydrobromide.
    Diab M; Coloe J; Bechtel MA
    Cutis; 2009 Mar; 83(3):139-40. PubMed ID: 19363906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine extended release in Alzheimer's disease: profile report.
    Robinson DM; Plosker GL
    Drugs Aging; 2006; 23(10):839-42. PubMed ID: 17067186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.